Table of Contents Author Guidelines Submit a Manuscript
Research Article

Safety of intravenous immunoglobulin (Tegeline®), administered at home in patients with autoimmune disease: results of a French study

Received 22 November 2017; Accepted 31 January 2018

Academic Editor: Hiroshi Tanaka